These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11158856

  • 1. How renal cytokines and growth factors contribute to renal disease progression.
    Benigni A, Remuzzi G.
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S21-4. PubMed ID: 11158856
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
    Zoja C, Liu XH, Abbate M, Corna D, Schiffrin EL, Remuzzi G, Benigni A.
    Exp Nephrol; 1998 Jan; 6(2):121-31. PubMed ID: 9567218
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endothelin antagonists and renal protection.
    Benigni A, Perico N, Remuzzi G.
    J Cardiovasc Pharmacol; 2000 Jan; 35(4 Suppl 2):S75-78. PubMed ID: 10976787
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition.
    Remuzzi G, Ruggenenti P, Perico N.
    Ann Intern Med; 2002 Apr 16; 136(8):604-15. PubMed ID: 11955029
    [Abstract] [Full Text] [Related]

  • 8. Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators.
    Zoja C, Benigni A, Remuzzi G.
    Exp Nephrol; 1999 Apr 16; 7(5-6):420-8. PubMed ID: 10559640
    [Abstract] [Full Text] [Related]

  • 9. Glomerular protein trafficking and progression of renal disease to terminal uremia.
    Benigni A, Remuzzi G.
    Semin Nephrol; 1996 May 16; 16(3):151-9. PubMed ID: 8734458
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glomerular hemodynamics in rats with chronic sodium depletion. Effect of saralasin.
    Steiner RW, Tucker BJ, Blantz RC.
    J Clin Invest; 1979 Aug 16; 64(2):503-12. PubMed ID: 457865
    [Abstract] [Full Text] [Related]

  • 13. The renin-angiotensin system in progression, remission and regression of chronic nephropathies.
    Aros C, Remuzzi G.
    J Hypertens Suppl; 2002 Jun 16; 20(3):S45-53. PubMed ID: 12184055
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The renoprotective action of angiotensin-converting enzyme inhibitors in diabetes.
    Ruggenenti P, Remuzzi G.
    Exp Nephrol; 1996 Jun 16; 4 Suppl 1():53-60. PubMed ID: 9001898
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells.
    Wolf G, Schroeder R, Ziyadeh FN, Stahl RA.
    Kidney Int; 2004 Nov 16; 66(5):1849-58. PubMed ID: 15496155
    [Abstract] [Full Text] [Related]

  • 20. Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration.
    Zoja C, Abbate M, Remuzzi G.
    Nephrol Dial Transplant; 2015 May 16; 30(5):706-12. PubMed ID: 25087196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.